S&P 500   3,963.06 (+0.36%)
DOW   32,196.43 (+0.28%)
QQQ   309.23 (-0.17%)
AAPL   159.80 (+0.55%)
MSFT   278.79 (+0.41%)
META   205.43 (+0.56%)
GOOGL   105.05 (-0.52%)
AMZN   98.04 (-0.68%)
TSLA   190.45 (-0.92%)
NVDA   266.02 (-2.17%)
NIO   9.01 (-2.80%)
BABA   86.61 (+0.10%)
AMD   97.63 (-2.64%)
T   18.55 (+0.49%)
F   11.47 (+0.44%)
MU   60.63 (-1.16%)
CGC   1.92 (+0.52%)
GE   90.84 (-0.82%)
DIS   93.93 (-1.98%)
AMC   4.49 (+0.45%)
PFE   40.38 (+0.50%)
PYPL   73.59 (+1.42%)
NFLX   326.60 (+1.94%)
S&P 500   3,963.06 (+0.36%)
DOW   32,196.43 (+0.28%)
QQQ   309.23 (-0.17%)
AAPL   159.80 (+0.55%)
MSFT   278.79 (+0.41%)
META   205.43 (+0.56%)
GOOGL   105.05 (-0.52%)
AMZN   98.04 (-0.68%)
TSLA   190.45 (-0.92%)
NVDA   266.02 (-2.17%)
NIO   9.01 (-2.80%)
BABA   86.61 (+0.10%)
AMD   97.63 (-2.64%)
T   18.55 (+0.49%)
F   11.47 (+0.44%)
MU   60.63 (-1.16%)
CGC   1.92 (+0.52%)
GE   90.84 (-0.82%)
DIS   93.93 (-1.98%)
AMC   4.49 (+0.45%)
PFE   40.38 (+0.50%)
PYPL   73.59 (+1.42%)
NFLX   326.60 (+1.94%)
S&P 500   3,963.06 (+0.36%)
DOW   32,196.43 (+0.28%)
QQQ   309.23 (-0.17%)
AAPL   159.80 (+0.55%)
MSFT   278.79 (+0.41%)
META   205.43 (+0.56%)
GOOGL   105.05 (-0.52%)
AMZN   98.04 (-0.68%)
TSLA   190.45 (-0.92%)
NVDA   266.02 (-2.17%)
NIO   9.01 (-2.80%)
BABA   86.61 (+0.10%)
AMD   97.63 (-2.64%)
T   18.55 (+0.49%)
F   11.47 (+0.44%)
MU   60.63 (-1.16%)
CGC   1.92 (+0.52%)
GE   90.84 (-0.82%)
DIS   93.93 (-1.98%)
AMC   4.49 (+0.45%)
PFE   40.38 (+0.50%)
PYPL   73.59 (+1.42%)
NFLX   326.60 (+1.94%)
S&P 500   3,963.06 (+0.36%)
DOW   32,196.43 (+0.28%)
QQQ   309.23 (-0.17%)
AAPL   159.80 (+0.55%)
MSFT   278.79 (+0.41%)
META   205.43 (+0.56%)
GOOGL   105.05 (-0.52%)
AMZN   98.04 (-0.68%)
TSLA   190.45 (-0.92%)
NVDA   266.02 (-2.17%)
NIO   9.01 (-2.80%)
BABA   86.61 (+0.10%)
AMD   97.63 (-2.64%)
T   18.55 (+0.49%)
F   11.47 (+0.44%)
MU   60.63 (-1.16%)
CGC   1.92 (+0.52%)
GE   90.84 (-0.82%)
DIS   93.93 (-1.98%)
AMC   4.49 (+0.45%)
PFE   40.38 (+0.50%)
PYPL   73.59 (+1.42%)
NFLX   326.60 (+1.94%)
NYSE:GLS

Gelesis - GLS News Today

$0.16
-0.01 (-4.91%)
(As of 03/24/2023 02:15 PM ET)
Add
Compare
Today's Range
$0.14
▼
$0.17
50-Day Range
$0.11
▼
$0.40
52-Week Range
$0.11
▼
$6.19
Volume
166,346 shs
Average Volume
384,588 shs
Market Capitalization
$11.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.15
Get Gelesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GLS and its competitors with MarketBeat's FREE daily newsletter.


GLS Media Mentions By Week

GLS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GLS
News Sentiment
▼
0.17

0.36
▲
Average
Medical
News Sentiment

GLS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GLS Articles
This Week
▼
3

0
▲
GLS Articles
Average Week

SourceHeadline
MarketBeat logoGelesis (GLS) Set to Announce Earnings on Wednesday
americanbankingnews.com - March 21 at 9:06 AM
MarketBeat logoGelesis (GLS) Scheduled to Post Earnings on Wednesday
americanbankingnews.com - March 21 at 8:15 AM
seekingalpha.com logoGLS Gelesis Holdings, Inc.
seekingalpha.com - January 27 at 6:15 PM
finance.yahoo.com logoGelesis to Participate in the 25th Annual ICR Conference
finance.yahoo.com - January 5 at 7:59 AM
technews.tmcnet.com logoNYSE to Suspend Trading Immediately in Warrants of Gelesis Holdings, Inc. (GLS WS) and Commence Delisting Proceedings
technews.tmcnet.com - January 4 at 8:15 PM
finance.yahoo.com logoGelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conference
finance.yahoo.com - November 21 at 12:07 PM
finance.yahoo.com logoGelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance
finance.yahoo.com - November 18 at 8:08 PM
seekingalpha.com logoGelesis Holdings, Inc. (GLS) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 14 at 7:35 PM
finance.yahoo.com logoGelesis Reports Third Quarter 2022 Results
finance.yahoo.com - November 14 at 10:22 AM
finance.yahoo.com logoGelesis to Report Third Quarter 2022 Financial Results on November 14, 2022
finance.yahoo.com - November 7 at 8:43 AM
finance.yahoo.com logoGelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance
finance.yahoo.com - November 4 at 7:55 PM
finance.yahoo.com logoData Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to Prebiotics
finance.yahoo.com - November 2 at 7:09 PM
finance.yahoo.com logoDr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Week
finance.yahoo.com - November 1 at 6:48 PM
ca.finance.yahoo.com logoInvestors in Gelesis Holdings (NYSE:GLS) have unfortunately lost 89% over the last year
ca.finance.yahoo.com - October 5 at 9:30 AM
morningstar.com logoGelesis Holdings Inc GLS Stock Analysis
morningstar.com - September 9 at 10:56 PM
finance.yahoo.com logoGelesis to Participate in the Jefferies Virtual Fitness & Wellness Summit
finance.yahoo.com - September 8 at 11:53 AM
finance.yahoo.com logoClinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome
finance.yahoo.com - August 25 at 9:47 AM
nasdaq.com logoInvestors one-year losses grow to 89% as the stock sheds US$21m this past week
nasdaq.com - August 24 at 10:04 AM
finance.yahoo.com logoREPLAY: Fight Obesity With Biotech – Gelesis CEO, CFO in Fireside Chat
finance.yahoo.com - August 17 at 8:09 PM
msn.com logoAnalyzing Gelesis Holdings Short Interest
msn.com - August 17 at 3:05 PM
finance.yahoo.com logoGelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ET
finance.yahoo.com - August 17 at 10:04 AM
finance.yahoo.com logoArming Consumers to Fight Obesity with Biotech – Join CEO and CFO of Gelesis in Fireside Chat Wednesday at 2 ET
finance.yahoo.com - August 16 at 1:58 PM
seekingalpha.com logoGelesis Holdings, Inc. (GLS) CEO Yishai Zohar on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 5:25 PM
finance.yahoo.com logoGelesis Reports Second Quarter 2022 Results
finance.yahoo.com - August 15 at 5:25 PM
finance.yahoo.com logoGelesis to Report Second Quarter 2022 Financial Results on August 15, 2022
finance.yahoo.com - August 4 at 8:00 PM
seekingalpha.com logoGelesis announces additional $15M pre-order for Plenity
seekingalpha.com - June 21 at 8:49 AM
finance.yahoo.com logoOver the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New Study
finance.yahoo.com - June 5 at 3:31 PM
finance.yahoo.com logoMicrobiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary Hydrogel
finance.yahoo.com - June 4 at 11:34 AM
nasdaq.com logoGelesis Holdings, Inc. Common Stock (GLS)
nasdaq.com - May 28 at 8:57 PM
investing.com logoGelesis Holdings Inc (GLS)
investing.com - May 27 at 3:51 AM
finance.yahoo.com logoGelesis to Participate in Upcoming Investor Conferences
finance.yahoo.com - May 18 at 8:53 PM
seekingalpha.com logoGelesis Holdings' (GLS) CEO Yishai Zohar on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 4:38 AM
seekingalpha.com logoGelesis Holdings GAAP EPS of -$0.70, revenue of $7.51M
seekingalpha.com - May 13 at 3:22 AM
finance.yahoo.com logoGelesis to Report First Quarter 2022 Financial Results on May 12, 2022
finance.yahoo.com - May 9 at 9:20 AM
finance.yahoo.com logoClinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetes
finance.yahoo.com - May 4 at 7:51 AM
finance.yahoo.com logoGelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
finance.yahoo.com - April 29 at 11:03 AM
Get Gelesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GLS and its competitors with MarketBeat's FREE daily newsletter.

This page (NYSE:GLS) was last updated on 3/24/2023 by MarketBeat.com Staff